Mapping Epileptic Networks Using Multimodal Imaging

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorImagine Institute

About this trial

Currently, mapping the epileptogenic zone is based on a comprehensive preoperative assessment involving clinical, imaging and electrophysiological examinations.

To reduce the need for invasive stereoelectroencephalography (SEEG) explorations, electrophysiological and imaging methods have been developed, such as resting-state functional MRI (fMRI) coupled with electroencephalogram and arterial spin-labeling perfusion MRI (ASL-MRI).

It has been published that these new methods enable precise delineation of the epileptogenic zone and better preparation for surgery.

The aim is to determine whether, in children with focal lesional epilepsy, the combination of ASL-MRI-EEG and resting-state fMRI-EEG enables precise identification of the epileptogenic zone to be defined by SEEG, the current reference examination.

Eligibility criteria

Qualifiers

Be under 18 years of age on the day of inclusion.

refractory focal lesional epilepsy

rare non-lesional epilepsy

Present abnormalities (spikes) on the intercritical EEG

Disqualifiers

Requiring general anesthesia for MRI

Require sedation specifically for research

Have generalized epilepsy

Be deprived of liberty or under guardianship.

Trial design

Treatments tested in this trial

  • Secondary data collection

Treatment groups

75 Participants
are divided into 1 treatment group

Sponsors and collaborators